CrystalGenomics Inc (083790) — Capital Reinvestment Ratio

Latest as of June 2018: 0.01x

CrystalGenomics Inc (083790) has a Capital Reinvestment Ratio of 0.01x as of June 2018, meaning it reinvests 0% of its operating cash flow (₩4.21 Billion) in capital expenditures (₩22.51 Million). Check how tangible is CrystalGenomics Inc's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

₩4.21 Billion
KRW

Capital Expenditures

₩22.51 Million
KRW

Data as of

Jun 2018
Most recent filing

CrystalGenomics Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks CrystalGenomics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does CrystalGenomics Inc generate cash.

Annual Capital Reinvestment Ratio for CrystalGenomics Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for CrystalGenomics Inc from 2017 to 2017. See CrystalGenomics Inc (083790) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2017 6.57x ₩1.63 Billion ₩10.74 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow